BridgeBio Pharma Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -16.6% | +55.4% | -6.5% | -16.3% | +38.3% | -4.1% | +22.5% | -7.6% | -6.2% | +46.5% | -11.2% | |
| – | -18.7% | +64.0% | -21.3% | -27.9% | +62.1% | -3.5% | +31.2% | -8.0% | -10.2% | +56.4% | -7.2% | |
| – | -25.6% | +26.4% | +15.1% | -51.3% | +155.7% | -20.6% | +38.6% | -14.2% | -11.3% | +54.3% | -23.0% | |
| – | -19.9% | +19.5% | +13.0% | -54.6% | +155.7% | -20.6% | +40.1% | -14.7% | -9.1% | +60.0% | -23.4% | |
| – | -66.1% | +13,349.1% | -99.7% | -27.6% | +887.9% | +2,341.0% | -33.3% | +51.6% | +19.7% | +47.2% | +24.0% | |
| – | +0.0% | – | – | – | – | – | +362.2% | +34.2% | +9.1% | +23.3% | +60.2% | |
| – | -2.2% | -2.3% | -2.3% | -2.4% | -2.4% | +16.2% | +6.2% | -2.4% | -2.5% | -2.6% | -2.6% | |
| – | +2.2% | -0.1% | -0.5% | +0.4% | +26.2% | +6.0% | +13.4% | +2.2% | +3.1% | +20.8% | +2.3% | |
| – | +35.6% | -1.6% | -5.0% | +3.6% | +10.9% | -1.5% | +15.6% | +23.2% | +33.0% | +183.5% | +9.1% | |
| – | -0.2% | +10.1% | +1.7% | -0.5% | -2.0% | +15.6% | +176.0% | -63.2% | +228.9% | +3,193.0% | -3.9% | |
| – | +138.3% | -55.6% | +283.4% | -26.3% | -28.0% | +186.2% | -5.1% | -28.4% | +93.7% | -19.8% | -6.4% | |
| – | +0.3% | -0.6% | +0.1% | +0.1% | +0.1% | +7.4% | +0.1% | +0.1% | +0.1% | +4.0% | +0.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.8% | +2.4% | +5.0% | +0.5% | +0.5% | +0.4% | +0.2% | +0.0% | +3.5% | -1.2% | +0.5% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.